UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

SCHEDULE 13D

 

Under the Securities Exchange Act of 1934

 

(Amendment No. 3)*

 

China Biologic Products Holdings, Inc.
(Name of Issuer)

 

Ordinary Shares, Par Value $0.0001
(Title of Class of Securities)

 

G21515104
(CUSIP Number)

 

Andrew Chan
Chief Financial Officer
Centurium Capital Management Ltd.
22th Floor, Building A1, Central Park Plaza
No. 10 Yard, Chaoyang Park South Road
Chaoyang District, Beijing
People’s Republic of China
+86 (10) 5929 3666

 

With a copy to:

 

Howard Zhang, Esq.
Davis Polk & Wardwell LLP 

2201 China World Office 2  

No. 1 Jian Guo Men Wai Avenue  

Chaoyang District, Beijing, 100004  

People’s Republic of China  

+86 10 8567 5000

 

(Name, Address and Telephone Number of Person Authorized to Receive Notices and
Communications)

 

January 7, 2019
(Date of Event which Requires Filing of this Statement)

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 1(f) or 1(g), check the following box. 

 

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

- 1

 

 

 

 

SCHEDULE 13D

 

CUSIP No.  G21515104  
1.

Names of Reporting Persons.

 

Beachhead Holdings Limited

2.

Check the Appropriate Box if a Member of a Group (See Instructions).

 

(a)  (b) 

3.

SEC Use Only

 

4.

Source of Funds (See Instructions)

 

OO

5.

Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)

 

6.

Citizenship or Place of Organization

 

Cayman Islands

Number of Shares

Beneficially Owned by

Each Reporting Person

With

7.

Sole Voting Power

 

0

8.

Shared Voting Power

 

4,447,798 ordinary shares (See Item 5)

9.

Sole Dispositive Power

 

0

10.

Shared Dispositive Power

 

4,447,798 ordinary shares (See Item 5)

11.

Aggregate Amount Beneficially Owned by Each Reporting Person

 

4,447,798 ordinary shares (See Item 5)

12.

Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)

 

13.

Percent of Class Represented by Amount in Row (11)

 

11.3%(1)

14.

Type of Reporting Person (See Instructions)

 

CO